glycine has been researched along with Choriocarcinoma in 3 studies
Choriocarcinoma: A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).
Excerpt | Relevance | Reference |
---|---|---|
"Transport of glycine in confluent monolayer cultures of JAR human placental choriocarcinoma cells was investigated." | 7.69 | Characterization of the glycine transport system GLYT 1 in human placental choriocarcinoma cells (JAR). ( Ganapathy, V; Leibach, FH; Liu, W, 1994) |
"Functional potencies of unlabeled compounds were characterized by [14C]glycine uptake into JAR (human placental choriocarcinoma) cells and synaptosomes." | 3.74 | A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies. ( Lemaire, W; Lindsley, CW; Miller, PJ; O'Brien, JA; O'Malley, SS; Raab, C; Sur, C; Wallace, MA; Williams, DL; Zeng, Z; Zhao, Z, 2008) |
"Augmentation strategy in the treatment of schizophrenia with the NMDA receptor co-agonist glycine has demonstrated significant improvement in patient symptoms." | 3.72 | Effects of typical and atypical antipsychotics on human glycine transporters. ( Conn, PJ; Mallorga, PJ; Pettibone, DJ; Sur, C; Williams, JB, 2004) |
"Transport of glycine in confluent monolayer cultures of JAR human placental choriocarcinoma cells was investigated." | 3.69 | Characterization of the glycine transport system GLYT 1 in human placental choriocarcinoma cells (JAR). ( Ganapathy, V; Leibach, FH; Liu, W, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Williams, JB | 1 |
Mallorga, PJ | 1 |
Conn, PJ | 1 |
Pettibone, DJ | 1 |
Sur, C | 2 |
Zeng, Z | 1 |
O'Brien, JA | 1 |
Lemaire, W | 1 |
O'Malley, SS | 1 |
Miller, PJ | 1 |
Zhao, Z | 1 |
Wallace, MA | 1 |
Raab, C | 1 |
Lindsley, CW | 1 |
Williams, DL | 1 |
Liu, W | 1 |
Leibach, FH | 1 |
Ganapathy, V | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Glycine Transport Inhibition on Brain Glycine Concentration[NCT00538070] | 68 participants (Actual) | Interventional | 2007-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 other studies available for glycine and Choriocarcinoma
Article | Year |
---|---|
Effects of typical and atypical antipsychotics on human glycine transporters.
Topics: Amino Acid Transport Systems, Neutral; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chlori | 2004 |
A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
Topics: Animals; Autoradiography; Benzamides; Binding, Competitive; Brain; Carbon Radioisotopes; Cell Line, | 2008 |
Characterization of the glycine transport system GLYT 1 in human placental choriocarcinoma cells (JAR).
Topics: Alanine; Amino Acid Transport Systems, Neutral; Anions; Biological Transport; Carrier Proteins; Cati | 1994 |